Impact of renal dysfunction and glucometabolic status on one month mortality after acute myocardial infarction

References

• Antman E. M., Cohen M., Bernink P. J., McCabe C. H., Horacek T., Papuchis G., et al. The TIMI risk score for unstable angina/non‐ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000; 284: 835–42
   PubMed Web of Science ®Google Scholar
• Morrow D. A., Antman E. M., Charlesworth A., Cairns R., Murphy S. A., de Lemos J. A., et al. TIMI risk score for ST‐elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000; 102: 2031–7
   PubMed Web of Science ®Google Scholar
• Morrow D. A., Antman E. M., Giugliano R. P., Cairns R., Charlesworth A., Murphy S. A., et al. A simple risk index for rapid initial triage of patients with ST‐elevation myocardial infarction: an InTIME II substudy. Lancet 2001; 358: 1571–5
   PubMed Web of Science ®Google Scholar
• Boersma E., Pieper K. S., Steyerberg E. W., Wilcox R. G., Chang W. C., Lee K. L., et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST‐segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation 2000; 101: 2557–67
   PubMed Web of Science ®Google Scholar
• Sabatine M. S., Januzzi J. L., Snapinn S., Theroux P., Jang I. K. A risk score system for predicting adverse outcomes and magnitude of benefit with glycoprotein IIb/IIIa inhibitor therapy in patients with unstable angina pectoris. Am J Cardiol 2001; 88: 488–92
   Google Scholar
• Eagle K. A., Lim M. J., Dabbous O. H., Pieper K. S., Goldberg R. J., Van de Werf F., et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6‐month postdischarge death in an international registry. JAMA 2004; 291: 2727–33
   PubMed Web of Science ®Google Scholar
• Wiviott S. D., Morrow D. A., Frederick P. D., Antman E. M., Braunwald E. Application of the thrombolysis in myocardial infarction risk index in non‐ST‐segment elevation myocardial infarction: evaluation of patients in the National Registry of Myocardial Infarction. J Am Coll Cardiol 2006; 47: 1553–8
   Google Scholar
• Kannel W. B., McGee D. L. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979; 241: 2035–8
   PubMed Web of Science ®Google Scholar
• Abbud Z. A., Shindler D. M., Wilson A. C., Kostis J. B. Effect of diabetes mellitus on short‐ and long‐term mortality rates of patients with acute myocardial infarction: a statewide study. Myocardial Infarction Data Acquisition System Study Group. Am Heart J 1995; 130: 51–8
   Google Scholar
• Timmer J. R., Van Der Horst I. C., Ottervanger J. P., Henriques J. P., Hoorntje J. C., De Boer M. J., et al. Prognostic value of admission glucose in non‐diabetic patients with myocardial infarction. Am Heart J 2004; 148: 399–404
   PubMedGoogle Scholar
• Tansey M. J., Opie L. H. Plasma glucose on admission to hospital as a metabolic index of the severity of acute myocardial infarction. Can J Cardiol 1986; 2: 326–31
   Google Scholar
• Zeller M., Cottin Y., Brindisi M. C., Dentan G., Laurent Y., Janin‐Manificat L., et al. Impaired fasting glucose and cardiogenic shock in patients with acute myocardial infarction. Eur Heart J 2004; 25: 308–12
   Google Scholar
• Oswald G. A., Smith C. C., Betteridge D. J., Yudkin J. S. Determinants and importance of stress hyperglycaemia in non‐diabetic patients with myocardial infarction. Br Med J. (Clin Res Ed) 1986; 293: 917–22
   PubMed Web of Science ®Google Scholar
• O'Sullivan J. J., Conroy R. M., Robinson K., Hickey N., Mulcahy R. In‐hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabetes Care 1991; 14: 758–60
   Google Scholar
• Norhammar A., Tenerz A., Nilsson G., Hamsten A., Efendic S., Ryden L., et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002; 359: 2140–4
   PubMed Web of Science ®Google Scholar
• Malmberg K., Norhammar A., Wedel H., Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long‐term results from the Diabetes and Insulin‐Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999; 99: 2626–32
   PubMed Web of Science ®Google Scholar
• Fisman E. Z., Motro M., Tenenbaum A., Boyko V., Mandelzweig L., Behar S. Impaired fasting glucose concentrations in nondiabetic patients with ischemic heart disease: a marker for a worse prognosis. Am Heart J 2001; 141: 485–90
   PubMed Web of Science ®Google Scholar
• Schnell O., Schafer O., Kleybrink S., Doering W., Standl E., Otter W. Intensification of Therapeutic Approaches Reduces Mortality in Diabetic Patients With Acute Myocardial Infarction: The Munich registry. Diabetes Care 2004; 27: 455–60
   Google Scholar
• Schiele F., Descotes‐Genon V., Seronde M. F., Blonde M. C., Legalery P., Meneveau N., et al. Predictive value of admission hyperglycaemia on mortality in patients with acute myocardial infarction. Diabet Med 2006; 23: 1370–6
   Google Scholar
• Levey A. S., Bosch J. P., Lewis J. B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461–70
   PubMed Web of Science ®Google Scholar
• Gibson C. M., Pinto D. S., Murphy S. A., Morrow D. A., Hobbach H. P., Wiviott S. D., et al. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol 2003; 42: 1535–43
   PubMed Web of Science ®Google Scholar
• Al Suwaidi J., Reddan D. N., Williams K., Pieper K. S., Harrington R. A., Califf R. M., et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002; 106: 974–80
   PubMed Web of Science ®Google Scholar
• Schiele F., Legalery P., Didier K., Meneveau N., Seronde M. F., Caulfield F., et al. Impact of renal dysfunction on 1‐year mortality after acute myocardial infarction. Am Heart J 2006; 151: 661–7
   PubMed Web of Science ®Google Scholar
• Januzzi J. L., Cannon C. P., DiBattiste P. M., Murphy S., Weintraub W., Braunwald E. Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS‐TIMI 18 Trial). Am J Cardiol 2002; 90: 1246–9
   PubMed Web of Science ®Google Scholar
• Best P. J., Lennon R., Ting H. H., Bell M. R., Rihal C. S., Holmes D. R., et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2002; 39: 1113–9
   PubMed Web of Science ®Google Scholar
• Peterson E. D., Pollack C. V., Jr., Roe M. T., Parsons L. S., Littrell K. A., Canto J. G., et al. Early use of glycoprotein IIb/IIIa inhibitors in non‐ST‐elevation acute myocardial infarction: observations from the National Registry of Myocardial Infarction 4. J Am Col Cardiol 2003; 42: 45–53
   PubMed Web of Science ®Google Scholar
• Mukherjee D., Fang J., Chetcuti S., Moscucci M., Kline‐Rogers E., Eagle K. A. Impact of Combination Evidence‐Based Medical Therapy on Mortality in Patients With Acute Coronary Syndromes. Circulation 2004; 109: 745–9
   PubMed Web of Science ®Google Scholar
• Gulati M., Patel S., Jaffe A. S., Joseph A. J., Calvin J. E., Jr. Impact of contemporary guideline compliance on risk stratification models for acute coronary syndromes in The Registry of Acute Coronary Syndromes. Am J Cardiol 2004; 94: 873–8
   Google Scholar
• Schiele F., Meneveau N., Seronde M. F., Caulfield F., Fouche R., Lassabe G., et al. Compliance with guidelines and 1‐year mortality in patients with acute myocardial infarction: a prospective study. Eur Heart J 2005; 26: 873–80
   PubMed Web of Science ®Google Scholar
• Fox K. A., Goodman S. G., Anderson F. A., Jr., Granger C. B., Moscucci M., Flather M. D., et al. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003; 24: 1414–24
   PubMed Web of Science ®Google Scholar
• K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1–266
   PubMed Web of Science ®Google Scholar
• Wiviott S. D., Morrow D. A., Frederick P. D., Giugliano R. P., Gibson C. M., McCabe C. H., et al. Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction‐3 and ‐4: a simple index that predicts mortality in ST‐segment elevation myocardial infarction. J Am Coll Cardiol 2004; 44: 783–9
   PubMed Web of Science ®Google Scholar
• DeLong E. R., DeLong D. M., Clarke‐Pearson D. L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837–45
   PubMed Web of Science ®Google Scholar
• Song H. H. Analysis of correlated ROC areas in diagnostic testing. Biometrics 1997; 53: 370–82
   Web of Science ®Google Scholar
• Suleiman M., Hammerman H., Boulos M., Kapeliovich M. R., Suleiman A., Agmon Y., et al. Fasting glucose is an important independent risk factor for 30‐day mortality in patients with acute myocardial infarction: a prospective study. Circulation 2005; 111: 754–60
   PubMed Web of Science ®Google Scholar
• Capes S. E., Hunt D., Malmberg K., Gerstein H. C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355: 773–8
   PubMed Web of Science ®Google Scholar
• Mizock B. A. Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med 1995; 98: 75–84
   PubMed Web of Science ®Google Scholar
• Otter W., Kleybrink S., Doering W., Standl E., Schnell O. Hospital outcome of acute myocardial infarction in patients with and without diabetes mellitus. Diabet Med 2004; 21: 183–7
   PubMed Web of Science ®Google Scholar
• Granger C. B., Goldberg R. J., Dabbous O., Pieper K. S., Eagle K. A., Cannon C. P., et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003; 163: 2345–53
   PubMed Web of Science ®Google Scholar
• Shlipak M. G., Katz R., Sarnak M. J., Fried L. F., Newman A. B., Stehman‐Breen C., et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 2006; 145: 237–46
   PubMed Web of Science ®Google Scholar
• Jernberg T., Lindahl B., James S., Larsson A., Hansson L. O., Wallentin L. Cystatin C: a novel predictor of outcome in suspected or confirmed non‐ST‐elevation acute coronary syndrome. Circulation 2004; 110: 2342–8
   PubMed Web of Science ®Google Scholar
• Mann J. F., Gerstein H. C., Pogue J., Bosch J., Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001; 134: 629–36
   PubMed Web of Science ®Google Scholar
• Keeley E. C., Kadakia R., Soman S., Borzak S., McCullough P. A. Analysis of long‐term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol 2003; 92: 509–14
   PubMed Web of Science ®Google Scholar
• Bhatt D. L., Roe M. T., Peterson E. D., Li Y., Chen A. Y., Harrington R. A., et al. Utilization of early invasive management strategies for high‐risk patients with non‐ST‐segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA 2004; 292: 2096–104
   PubMed Web of Science ®Google Scholar
• Shlipak M. G., Heidenreich P. A., Noguchi H., Chertow G. M., Browner W. S., McClellan M. B. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 2002; 137: 555–62
   PubMed Web of Science ®Google Scholar
• Wright R. S., Reeder G. S., Herzog C. A., Albright R. C., Williams B. A., Dvorak D. L., et al. Acute myocardial infarction and renal dysfunction: a high‐risk combination. Ann Intern Med 2002; 137: 563–70
   PubMed Web of Science ®Google Scholar